Abstract: Disclosed is an ultra-thin composite transparent conductive film, including: a transparent substrate; a first UV glue layer disposed on one side of the transparent substrate, pattern-imprinted and cured to form a first grid-shaped groove, the first grid-shaped groove being filled with conductive materials to form a first conductive layer; a second UV glue layer disposed on one side of the first UV glue layer away from the transparent substrate to provide a reinforced insulating support layer; and a third UV glue layer disposed on one side of the second UV glue layer away from the transparent substrate, pattern-imprinted and cured to form a second grid-shaped groove, the second grid-shaped groove being filled with conductive materials to form a second conductive layer, where a thickness of the reinforced insulating support layer is in a range of 5-10 micrometers.

Abstract: Disclosed is an ultra-thin composite transparent conductive film, comprising: a transparent substrate; a first UV glue layer disposed on one side of the transparent substrate, pattern-imprinted and cured to form a first grid-shaped groove and a first lead groove, the first grid-shaped groove and the first lead groove being filled with conductive materials to form a first conductive layer and a first lead region respectively, depth of the first grid-shaped groove and the first lead groove being smaller than a thickness of the first UV glue layer; a second UV glue layer disposed on one side of the first UV glue layer away from the transparent substrate and used as a reinforced insulating support layer; and a third UV glue layer disposed on one side of the second UV glue layer away from the transparent substrate, pattern-imprinted and cured to form a second grid-shaped groove and a second lead groove, the second grid-shaped groove and the second lead groove being filled with conductive materials to form a second

Abstract: Provided is a low-molecular-weight holothurian glycosarninoglycan, with the constituent units thereof being a glucuronic acid group, an N-acetaminogalactose group and a fucose group, and a sulfate ester group or acetyl ester group thereof. Glucuronic acid and N-acetaminogalactose are interconnected via ?(1-3) and ?(1-4) glucosidic bonds to form a backbone of a disaccharide repeating structural unit, and a fucose group is connected to the backbone as a side chain. On a molar ratio basis, the ratio of the glucuronic acid group:the N-acetaminogalactose group:the fucose group is 1:(0.8-1.2):(0.6-1.2). In the structure of the low-molecular-weight holothurian glycosaminoglycan, 10-30% of glucuronic acid groups are modified, on the 2-position, with a sulfate ester group, and the rest are hydroxyl groups; and a proportion of 10-30% of fucose groups is modified, on the 2-position, with an acetyl ester group, and the rest are hydroxyl or sulfate ester groups.

Abstract: Provided is a low-molecular-weight holothurian glycosarninoglycan, with the constituent units thereof being a glucuronic acid group, an N-acetaminogalactose group and a fucose group, and a sulfate ester group or acetyl ester group thereof. Glucuronic acid and N-acetaminogalactose are interconnected via ?(1-3) and ?(1-4) glucosidic bonds to form a backbone of a disaccharide repeating structural unit, and a fucose group is connected to the backbone as a side chain. On a molar ratio basis, the ratio of the glucuronic acid group:the N-acetaminogalactose group:the fucose group is 1:(0.8-1.2):(0.6-1.2). In the structure of the low-molecular-weight holothurian glycosaminoglycan, 10-30% of glucuronic acid groups are modified, on the 2-position, with a sulfate ester group, and the rest are hydroxyl groups; and a proportion of 10-30% of fucose groups is modified, on the 2-position, with an acetyl ester group, and the rest are hydroxyl or sulfate ester groups.

Abstract: Disclosed is an ultra-thin composite transparent conductive film, comprising: a transparent substrate; a first UV glue layer disposed on one side of the transparent substrate, pattern-imprinted and cured to form a first grid-shaped groove and a first lead groove, the first grid-shaped groove and the first lead groove being filled with conductive materials to form a first conductive layer and a first lead region respectively, depth of the first grid-shaped groove and the first lead groove being smaller than a thickness of the first UV glue layer; a second UV glue layer disposed on one side of the first UV glue layer away from the transparent substrate and used as a reinforced insulating support layer; and a third UV glue layer disposed on one side of the second UV glue layer away from the transparent substrate, pattern-imprinted and cured to form a second grid-shaped groove and a second lead groove, the second grid-shaped groove and the second lead groove being filled with conductive materials to form a second

Abstract: The present invention relates to a cosmetic container which provides a non-woven substrate and an applicator, which may be used for the application of cosmetic or personal care compositions to the skin or hair. The non-woven substrate preferably uses crimped microfibers and may be layered, modified to include a peripheral liquid-impermeable rim, and combinations thereof. The composition of the fibers may also be tailored for maximum stability when used in combination with particular formulations, such as sunscreens.

Abstract: The present invention discloses an ovine enoxaparin sodium, a preparation method therefor, and an application thereof. The ovine enoxaparin sodium is prepared from ovine heparin. Compared with enoxaparin sodium derived from porcine intestinal mucosa heparin, both the chemical structures (disaccharide compositions) and the physiochemical properties are different. Through process of optimization and precipitation, the ovine enoxaparin sodium prepared meets the enoxaparin sodium specifications in the USP 37 and the EP 8.0 as well as specifications in current editions of the USP 39 and the EP 8.6. Also provided are two types of ovine enoxaparin sodium injections, preparation methods therefor, and anticoagulation properties in animal model. The raw material used in the preparation is ovine, which is a Halal material compared to porcine enoxaparin sodium. Therefore, the ovine enoxaparin sodium and the injections thereof are an Halal anticoagulant medicine.

Abstract: A search recommendation method and a search recommendation device are provided. The method comprises: receiving a query; generating an interactive question according to the query, and then providing the interactive question to a user; receiving an answer of the interactive question from the user, and then determining a level of the user according to the answer; and generating a recommendation according to the level of the user and the query and providing the recommendation to the user.

Abstract: Preparations of low molecular weight heparins (LMWHs) having improved properties, e.g., properties that provide a clinical advantage, are provided herein. Methods of making and using such preparations as well as methods of analyzing starting materials, processing, intermediates and final products in the production of such LMWH preparations are provided.

Abstract: A blood pressure detection method and the apparatus therefor, in which the method includes the steps of recording a voice describing the patient's state when measuring blood pressure and transmitting blood pressure data and voice data to a network server. The network server transforms the blood pressure data of the patient for a given time period into a blood pressure variation curve based upon a plurality of blood pressure measurements. The blood pressure measurement apparatus preferably includes a blood pressure measurement unit with an air pump, an inflatable cuff and a pressure sensor, and a computer processing unit having a CPU, a memory for data storage, a communication interface and a human-machine interface.

Abstract: Methods and materials for the production of the high intensity sweetener, monatin, in stereoisomerically-pure or stereoisomerically-enriched form are disclosed. For example, methods using stereoisoselective hydrolysis and separation of a monatin-derived lactone ester are disclosed.

Abstract: Preparations of low molecular weight heparins (LMWHs) having improved properties, e.g., properties that provide a clinical advantage, are provided herein. Methods of making and using such preparations as well as methods of analyzing starting materials, processing, intermediates and final products in the production of such LMWH preparations are provided.

Abstract: Methods and materials for the production of the high intensity sweetener, monatin, in stereoisomerically-pure or stereoisomerically-enriched form are disclosed. For example, methods using stereoisoselective hydrolysis and separation of a monatin-derived lactone ester are disclosed.

Abstract: Preparations of low molecular weight heparins (LMWHs) having improved properties, e.g., properties that provide a clinical advantage, are provided herein. Methods of making and using such preparations as well as methods of analyzing starting materials, processing, intermediates and final products in the production of such LMWH preparations are provided.

Abstract: The satellite communication system comprises a plurality of satellites. The frequency bandwidth of the return link to each satellite is subdivided into a plurality of channels. The method includes steps of finding a total interference in each channel, calculating a predicted total interference from addition of a first user terminal to each channel, determining if the predicted total interference is a minimum, and allocating the first channel to the first user terminal. The predicted total interference is calculated for each channel of the plurality of channels in the return link to each of at least two satellites. The first channel is allocated to the first user terminal if the predicted total interference in the first channel is the minimum value.